Cite
HARVARD Citation
Canovatchel, W. et al. (n.d.). Efficacy of canagliflozin (CANA) versus dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients with T2DM: Results from RCTs and Real-World (RW) study. Diabetes research and clinical practice. pp. S118-. [Online].